{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:16:55Z","timestamp":1790255815863,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Gaziantep Islam Science and Technology University","award":["2025-YLP- TF-0002"],"award-info":[{"award-number":["2025-YLP- TF-0002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01034-7","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:42:32Z","timestamp":1763984552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Selinexor, a selective inhibitor of nuclear export, shows anti-proliferative and anti-migratory effects on male germ cells in vitro"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-7122","authenticated-orcid":false,"given":"Mustafa","family":"\u00d6ztatl\u0131c\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2133-7035","authenticated-orcid":false,"given":"Parmila Rahmat","family":"Zada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5256-1259","authenticated-orcid":false,"given":"Rukiye Bet\u00fcl","family":"\u00c7olaksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4089-5243","authenticated-orcid":false,"given":"B\u00fc\u015fra \u015een","family":"Hal\u0131c\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6749-9665","authenticated-orcid":false,"given":"H\u00fclya","family":"\u00d6ztatl\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"3","key":"1034_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1034_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83\u2013103. https:\/\/doi.org\/10.3322\/caac.21219.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1034_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"1034_CR4","doi-asserted-by":"publisher","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","volume":"50","author":"R Kaur","year":"2023","unstructured":"Kaur R, Bhardwaj A, Gupta S. Cancer treatment therapies: traditional to modern approaches to combat cancers. Mol Biol Rep. 2023;50(11):9663\u201376. https:\/\/doi.org\/10.1007\/s11033-023-08809-3.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"1034_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1470-2045(05)70092-9","volume":"6","author":"WHB Wallace","year":"2005","unstructured":"Wallace WHB, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005;6(4):209\u201318. https:\/\/doi.org\/10.1016\/S1470-2045(05)70092-9.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1034_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1053\/j.seminoncol.2015.09.032","volume":"42","author":"S Liu","year":"2015","unstructured":"Liu S, Kurzrock R. Understanding toxicities of targeted agents: implications for anti-tumor activity and management. Semin Oncol. 2015;42(6):863\u201375. https:\/\/doi.org\/10.1053\/j.seminoncol.2015.09.032.","journal-title":"Semin Oncol"},{"issue":"20","key":"1034_CR7","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.3390\/ijms20205223","volume":"20","author":"E Ntemou","year":"2019","unstructured":"Ntemou E, Alexandri C, Lybaert P, Goossens E, Demeestere I. Oncofertility: Pharmacological protection and immature testicular tissue (ITT)-based strategies for prepubertal and adolescent male cancer patients. Int J Mol Sci. 2019;20(20):5223. https:\/\/doi.org\/10.3390\/ijms20205223.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1034_CR8","doi-asserted-by":"publisher","first-page":"e14368","DOI":"10.1111\/and.14368","volume":"54","author":"MY Adana","year":"2022","unstructured":"Adana MY, Imam A, Bello AA, Salawu OA, Ibrahim MT, Suleiman JB. Oral thymoquinone modulates cyclophosphamide-induced testicular toxicity in adolescent Wistar rats. Andrologia. 2022;54(4):e14368. https:\/\/doi.org\/10.1111\/and.14368.","journal-title":"Andrologia"},{"key":"1034_CR9","doi-asserted-by":"publisher","first-page":"877537","DOI":"10.3389\/fendo.2022.877537","volume":"13","author":"E Eugeni","year":"2022","unstructured":"Eugeni E, Arato I, Del Sordo R, Sidoni A, Garolla A, Ferlin A, Calafiore R, Brancorsini S, Mancuso F, Luca G. Fertility preservation and restoration options for pre-pubertal male cancer patients: current approaches. Front Endocrinol (Lausanne). 2022;13:877537. https:\/\/doi.org\/10.3389\/fendo.2022.877537.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1034_CR10","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/ijms21041454","volume":"21","author":"M Delessard","year":"2020","unstructured":"Delessard M, Saulnier J, Rives A, Dumont L, Rondanino C, Rives N. Exposure to chemotherapy during childhood or adulthood and consequences on spermatogenesis and male fertility. Int J Mol Sci. 2020;21(4):1454. https:\/\/doi.org\/10.3390\/ijms21041454.","journal-title":"Int J Mol Sci"},{"key":"1034_CR11","doi-asserted-by":"publisher","first-page":"102543","DOI":"10.1016\/j.ctrv.2023.102543","volume":"119","author":"M Horibe","year":"2023","unstructured":"Horibe M, Higano CS. The long-term impact of cancer therapy on male fertility: molecular mechanisms and fertility preservation strategies. Cancer Treat Rev. 2023;119:102543. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102543.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"1034_CR12","doi-asserted-by":"publisher","first-page":"R69","DOI":"10.1530\/EC-17-0382","volume":"7","author":"JB Stukenborg","year":"2018","unstructured":"Stukenborg JB, Jahnukainen K, Hutka M, Mitchell RT. Cancer treatment in childhood and testicular function: the importance of the somatic environment. Endocr Connect. 2018;7(2):R69\u201387. https:\/\/doi.org\/10.1530\/EC-17-0382.","journal-title":"Endocr Connect"},{"key":"1034_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.toxrep.2020.12.023","volume":"8","author":"F Lopes","year":"2021","unstructured":"Lopes F, Tholeti P, Adiga SK, Anderson RA, Mitchell RT, Spears N. Chemotherapy induced damage to spermatogonial stem cells in prepubertal mouse in vitro impairs long-term spermatogenesis. Toxicol Rep. 2021;8:114\u201323. https:\/\/doi.org\/10.1016\/j.toxrep.2020.12.023.","journal-title":"Toxicol Rep"},{"issue":"4","key":"1034_CR14","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/ijms21041454","volume":"21","author":"M Delessard","year":"2020","unstructured":"Delessard M, Saulnier J, Rives A, Dumont L, Rondanino C, Rives N. (2020). Exposure to chemotherapy during childhood or adulthood and consequences on spermatogenesis and male fertility. Int J Mol Sci, 21(4), 1454. https:\/\/doi.org\/10.3390\/ijms21041454","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1034_CR15","doi-asserted-by":"publisher","first-page":"100963","DOI":"10.1016\/j.currproblcancer.2023.100963","volume":"47","author":"G Bogani","year":"2023","unstructured":"Bogani G, Monk BJ, Coleman RL, Vergote I, Oakin A, Ray-Coquard I, Mariani A, Scambia G, Raspagliesi F, Bolognese B. Selinexor in patients with advanced and recurrent endometrial cancer. Curr Probl Cancer. 2023;47(6):100963. https:\/\/doi.org\/10.1016\/j.currproblcancer.2023.100963.","journal-title":"Curr Probl Cancer"},{"key":"1034_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40164-015-0002-5","volume":"4","author":"A Das","year":"2015","unstructured":"Das A, Wei G, Parikh K, Liu D. Selective inhibitors of nuclear export (SINE) in hematological malignancies. Exp Hematol Oncol. 2015;4:7. https:\/\/doi.org\/10.1186\/s40164-015-0002-5.","journal-title":"Exp Hematol Oncol"},{"key":"1034_CR17","doi-asserted-by":"publisher","first-page":"100758","DOI":"10.1016\/j.blre.2020.100758","volume":"46","author":"K Benkova","year":"2021","unstructured":"Benkova K, Mihalyova J, Hajek R, Jelinek T. Selinexor, selective inhibitor of nuclear export: unselective bullet for blood cancers. Blood Rev. 2021;46:100758. https:\/\/doi.org\/10.1016\/j.blre.2020.100758.","journal-title":"Blood Rev"},{"issue":"56","key":"1034_CR18","doi-asserted-by":"publisher","first-page":"30773","DOI":"10.18632\/oncotarget.25637","volume":"9","author":"T Kashyap","year":"2018","unstructured":"Kashyap T, Argueta C, Unger T, Klebanov B, Debler S, Senapedis W, Crochiere ML, Lee MS, Kauffman M, Shacham S, Landesman Y. Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents. Oncotarget. 2018;9(56):30773\u201386. https:\/\/doi.org\/10.18632\/oncotarget.25637.","journal-title":"Oncotarget"},{"issue":"1","key":"1034_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-020-00903-4","volume":"13","author":"NG Azizian","year":"2020","unstructured":"Azizian NG, Li Y. XPO1-dependent nuclear export as a target for cancer therapy. J Hematol Oncol. 2020;13(1):61. https:\/\/doi.org\/10.1186\/s13045-020-00903-4.","journal-title":"J Hematol Oncol"},{"key":"1034_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2014.03.002","volume":"27","author":"HYJ Fung","year":"2014","unstructured":"Fung HYJ, Chook YM. Atomic basis of CRM1-cargo recognition, release and Inhibition. Semin Cancer Biol. 2014;27:52\u201361. https:\/\/doi.org\/10.1016\/j.semcancer.2014.03.002.","journal-title":"Semin Cancer Biol"},{"key":"1034_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.semcancer.2014.03.001","volume":"27","author":"JG Turner","year":"2014","unstructured":"Turner JG, Dawson J, Cubitt CL, Baz R, Sullivan DM. Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents. Semin Cancer Biol. 2014;27:62\u201373. https:\/\/doi.org\/10.1016\/j.semcancer.2014.03.001.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1034_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/leu.2012.219","volume":"27","author":"J Etchin","year":"2013","unstructured":"Etchin J, Sun Q, Kentsis A, Farmer A, Zhang ZC, Sanda T, Mansour MR, Barcelo C, McCauley D, Kauffman M, Shacham S, Christie AL, Kung AL, Rodig SJ, Chook YM, Look AT. Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells. Leukemia. 2013;27(1):66\u201374. https:\/\/doi.org\/10.1038\/leu.2012.219.","journal-title":"Leukemia"},{"key":"1034_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.14744\/ijmb.2021.77487","volume":"4","author":"AT Ozdemir","year":"2021","unstructured":"Ozdemir AT, Oztatlici M, Ozgul OR, Cakir B, Ozbilgin K, Dariverenli E. The effects of preconditioning with IFN-\u03b3, IL-4, and IL-10 on costimulatory ligand expressions of mesenchymal stem cells. Int J Med Biochem. 2021;4:121\u201330. https:\/\/doi.org\/10.14744\/ijmb.2021.77487.","journal-title":"Int J Med Biochem"},{"issue":"5","key":"1034_CR24","first-page":"2389","volume":"25","author":"L Tang","year":"2020","unstructured":"Tang L, Qin Y, Ling K, Wan H. Eriodictyol inhibits the growth of CNE1 human nasopharyngeal cancer by targeting MEK\/ERK signalling pathway, inducing cellular autophagy and Inhibition of cell migration and invasion. J BUON. 2020;25(5):2389\u201394. https:\/\/pubmed.ncbi.nlm.nih.gov\/33277860\/.","journal-title":"J BUON"},{"issue":"1","key":"1034_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.52547\/ijrr.20.1.2","volume":"20","author":"C Kurtman","year":"2022","unstructured":"Kurtman C, \u00d6ztatl\u0131c\u0131 M, \u00dc\u00e7\u00f6z M, et al. Mitophagy in the A549 lung cancer cell line, radiation-induced damage, and the effect of ATM and PARKIN on the mitochondria. Int J Radiat Res. 2022;20(1):9\u201313. https:\/\/doi.org\/10.52547\/ijrr.20.1.2.","journal-title":"Int J Radiat Res"},{"issue":"21","key":"1034_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.38065\/euroasiaorg.962","volume":"9","author":"H Oztatlici","year":"2022","unstructured":"Oztatlici H, Oztatlici M, Dagl\u0131 SN, Saygili SK. Cefepime, a cephalosporin, induces the apoptosis and oxidative stress in NB2a neuroblastoma cells. Euroasia J Math Eng Nat Med Sci. 2022;9(21):79\u201386. https:\/\/doi.org\/10.38065\/euroasiaorg.962.","journal-title":"Euroasia J Math Eng Nat Med Sci"},{"issue":"1","key":"1034_CR27","doi-asserted-by":"publisher","first-page":"205873841983353","DOI":"10.1177\/2058738419833533","volume":"33","author":"SA Algaidi","year":"2019","unstructured":"Algaidi SA, Eldomiaty MA, Elbastwisy YM, Almasry SM, Desouky MK, Elnaggar AM. Effect of voluntary running on expression of myokines in brains of rats with depression. Int J ImmunoPathol Pharmacol. 2019;33(1):2058738419833533. https:\/\/doi.org\/10.1177\/2058738419833533.","journal-title":"Int J ImmunoPathol Pharmacol"},{"issue":"1","key":"1034_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.47162\/RJME.65.1.04","volume":"65","author":"M Oztatlici","year":"2024","unstructured":"Oztatlici M, Oztatlici H, Karadeniz Saygili S, Kaya I, Cingoz ID. Cyclophosphamide stimulates Endoplasmic reticulum stress and induces apoptotic cell death in human glioblastoma cell lines. Rom J Morphol Embryol. 2024;65(1):27\u201333. https:\/\/doi.org\/10.47162\/RJME.65.1.04.","journal-title":"Rom J Morphol Embryol"},{"issue":"9","key":"1034_CR29","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1038\/s41375-024-02343-2","volume":"38","author":"T Terasaki","year":"2024","unstructured":"Terasaki T, Semba Y, Sasaki K, Imanaga H, Setoguchi K, Yamauchi T, Hirabayashi S, Nakao F, Akahane K, Inukai T, Sanda T, Akashi K, Maeda T. The RNA helicases DDX19A\/B modulate Selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells. Leukemia. 2024;38(9):1918\u201328. https:\/\/doi.org\/10.1038\/s41375-024-02343-2.","journal-title":"Leukemia"},{"issue":"1","key":"1034_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/leu.2013.115","volume":"28","author":"YT Tai","year":"2014","unstructured":"Tai YT, Landesman Y, Acharya C, Calle Y, Zhong MY, Cea M, Tannenbaum D, Cagnetta A, Reagan M, Munshi AA, Senapedis W, Saint-Martin JR, Kashyap T, Shacham S, Kauffman M, Gu Y, Wu L, Ghobrial I, Zhan F, Kung AL, Schey SA, Richardson P, Munshi NC, Anderson KC. CRM1 Inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications. Leukemia. 2014;28(1):155\u201365. https:\/\/doi.org\/10.1038\/leu.2013.115.","journal-title":"Leukemia"},{"issue":"15","key":"1034_CR31","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1158\/1078-0432.CCR-16-2632","volume":"23","author":"JS Nair","year":"2017","unstructured":"Nair JS, Musi E, Schwartz GK. Selinexor (KPT-330) induces tumor suppression through nuclear sequestration of I\u03baB and downregulation of survivin. Clin Cancer Res. 2017;23(15):4301\u201311. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2632.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1034_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/bjh.18667","volume":"201","author":"CB Jing","year":"2023","unstructured":"Jing CB, Prutsch N, He S, Zimmerman MW, Landesman Y, Look AT. Synthetic lethal targeting of TET2-mutant Haematopoietic stem and progenitor cells by XPO1 inhibitors. Br J Haematol. 2023;201(3):489\u2013501. https:\/\/doi.org\/10.1111\/bjh.18667.","journal-title":"Br J Haematol"},{"issue":"12","key":"1034_CR33","doi-asserted-by":"publisher","first-page":"e1513","DOI":"10.1002\/ctm2.1513","volume":"13","author":"MH Uddin","year":"2023","unstructured":"Uddin MH, Al-Hallak MN, Khan HY, Aboukameel A, Li Y, Bannoura SF, Dyson G, Kim S, Mzannar Y, Azar I, Odisho T, Mohamed A, Landesman Y, Kim S, Beydoun R, Mohammad RM, Philip PA, Shields AF, Azmi AS. Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Clin Translational Med. 2023;13(12):e1513. https:\/\/doi.org\/10.1002\/ctm2.1513.","journal-title":"Clin Translational Med"},{"issue":"1","key":"1034_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10616-022-00555-x","volume":"75","author":"F Yuan","year":"2023","unstructured":"Yuan F, Yong J, Liu X, Wang Y. Selinexor assists Vorinostat in inhibiting HDAC activity via promoting the accumulation of Maspin in the nucleus of oral tongue squamous cell carcinoma cells. Cytotechnology. 2023;75(1):1\u201316. https:\/\/doi.org\/10.1007\/s10616-022-00555-x.","journal-title":"Cytotechnology"},{"issue":"5","key":"1034_CR35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00280-024-04704-1","volume":"94","author":"D Xiang","year":"2024","unstructured":"Xiang D, Wang M, Wu H, Chen X, Chen T, Yu D, Xiong L, Xu H, Luo M, Zhang S, Wu L, Yan J. Selinexor targeting XPO1 promotes PEG3 nuclear accumulation and suppresses cholangiocarcinoma progression. Cancer Chemother Pharmacol. 2024;94(5):669\u201383. https:\/\/doi.org\/10.1007\/s00280-024-04704-1.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1034_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-cellbio-101512-122353","volume":"29","author":"M Kanatsu-Shinohara","year":"2013","unstructured":"Kanatsu-Shinohara M, Shinohara T. Spermatogonial stem cell self-renewal and development. Annu Rev Cell Dev Biol. 2013;29:163\u201387. https:\/\/doi.org\/10.1146\/annurev-cellbio-101512-122353.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1034_CR37","doi-asserted-by":"publisher","first-page":"897062","DOI":"10.3389\/fendo.2022.897062","volume":"13","author":"MC Hofmann","year":"2022","unstructured":"Hofmann MC, McBeath E. Sertoli cell\u2013germ cell interactions within the niche: paracrine and juxtacrine molecular communications. Front Endocrinol (Lausanne). 2022;13:897062. https:\/\/doi.org\/10.3389\/fendo.2022.897062.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1034_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrm.2017.48","volume":"18","author":"HHY Chang","year":"2017","unstructured":"Chang HHY, Pannunzio NR, Adachi N, Lieber MR. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat Rev Mol Cell Biol. 2017;18(8):495\u2013506. https:\/\/doi.org\/10.1038\/nrm.2017.48.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1034_CR39","doi-asserted-by":"publisher","unstructured":"Yuan S, Zuo W, Liu T, Fu H. The therapeutic synergy of selinexor and venetoclax in mantle cell lymphoma through induction of DNA damage and perturbation of the DNA damage response. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231208608. https:\/\/doi.org\/10.1177\/15330338231208608.","DOI":"10.1177\/15330338231208608"},{"issue":"4","key":"1034_CR40","doi-asserted-by":"publisher","first-page":"662","DOI":"10.4161\/cc.9.4.10764","volume":"9","author":"M L\u00f6brich","year":"2010","unstructured":"L\u00f6brich M, Shibata A, Beucher A, Fisher A, Ensminger M, Goodarzi AA, Barton O, Jeggo PA. \u03b3H2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization. Cell Cycle. 2010;9(4):662\u20139. https:\/\/doi.org\/10.4161\/cc.9.4.10764.","journal-title":"Cell Cycle"},{"issue":"67","key":"1034_CR41","doi-asserted-by":"publisher","first-page":"111225","DOI":"10.18632\/oncotarget.22760","volume":"8","author":"GL Gravina","year":"2017","unstructured":"Gravina GL, Mancini A, Colapietro A, Marampon F, Sferra R, Pompili S, Biordi LA, Iorio R, Flati V, Argueta C, Landesman Y, Kauffman M, Shacham S, Festuccia C. Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer. Oncotarget. 2017;8(67):111225\u201345. https:\/\/doi.org\/10.18632\/oncotarget.22760.","journal-title":"Oncotarget"},{"issue":"24","key":"1034_CR42","doi-asserted-by":"publisher","first-page":"39460","DOI":"10.18632\/oncotarget.17063","volume":"8","author":"RT Burke","year":"2017","unstructured":"Burke RT, Marcus JM, Orth JD. Inhibition of exportin-1 function results in rapid cell cycle-associated DNA damage in cancer cells. Oncotarget. 2017;8(24):39460\u201375. https:\/\/doi.org\/10.18632\/oncotarget.17063.","journal-title":"Oncotarget"},{"key":"1034_CR43","doi-asserted-by":"publisher","unstructured":"Tan Y, Chen G, He RQ, Huang ZG, Dang YW, Luo JY, Huang WY, Huang SN, Liu R, Feng ZB. Clinicopathological and prognostic significance of XPO1 in solid tumors: meta-analysis and TCGA analysis. Expert Rev Mol Diagn. 2023 Jul-Dec;23(7):607\u201318. https:\/\/doi.org\/10.1080\/14737159.2023.2224505.","DOI":"10.1080\/14737159.2023.2224505"},{"issue":"1","key":"1034_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40164-023-00443-w","volume":"12","author":"S Mittal","year":"2023","unstructured":"Mittal S, Kadamberi IP, Chang H, Wang F, Kumar S, Tsaih SW, Walker CJ, Chaluvally-Raghavan P, Charlson J, Landesman Y, Pradeep S. Preclinical activity of Selinexor in combination with eribulin in uterine leiomyosarcoma. Experimental Hematol Oncol. 2023;12(1):78. https:\/\/doi.org\/10.1186\/s40164-023-00443-w.","journal-title":"Experimental Hematol Oncol"},{"issue":"6","key":"1034_CR45","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41419-019-1627-9","volume":"10","author":"ZC Zhu","year":"2019","unstructured":"Zhu ZC, Liu JW, Yang C, Zhao M, Xiong ZQ. XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis. Cell Death Dis. 2019;10(6):395. https:\/\/doi.org\/10.1038\/s41419-019-1627-9.","journal-title":"Cell Death Dis"},{"key":"1034_CR46","doi-asserted-by":"publisher","first-page":"216486","DOI":"10.1016\/j.canlet.2023.216486","volume":"580","author":"X Wang","year":"2024","unstructured":"Wang X, Xu J, Li Q, Zhang Y, Lin Z, Zhai X, Wang F, Huang J, Gao Q, Wen J, Li L, Feng Y, Luo H, Li Q, Liu X, Li J, Zhao F, Zhang L, Niu T, Sun C, Zheng Y. RNA-binding protein HnRNPU regulates multiple myeloma resistance to Selinexor. Cancer Lett. 2024;580:216486. https:\/\/doi.org\/10.1016\/j.canlet.2023.216486.","journal-title":"Cancer Lett"},{"issue":"4","key":"1034_CR47","first-page":"1085","volume":"32","author":"LH Lin","year":"2024","unstructured":"Lin LH, Gao SQ, Mei XQ, Lin DY, Chen YF, Lin SD, Zhuang LH, Lin CM. [Effect of Selinexor on proliferation and apoptosis of acute myeloid leukemia Kasumi-1 Cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024;32(4):1085\u201390. https:\/\/pubmed.ncbi.nlm.nih.gov\/39192402\/.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"10","key":"1034_CR48","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3390\/cells9102231","volume":"9","author":"S Martini","year":"2020","unstructured":"Martini S, Figini M, Croce A, Frigerio B, Pennati M, Gianni AM, De Marco C, Daidone MG, Argueta C, Landesman Y, Zaffaroni N, Satta A. Selinexor sensitizes TRAIL-R2-Positive TNBC cells to the activity of TRAIL-R2xCD3 bispecific antibody. Cells. 2020;9(10):2231. https:\/\/doi.org\/10.3390\/cells9102231.","journal-title":"Cells"},{"issue":"7","key":"1034_CR49","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3390\/ph17070894","volume":"17","author":"M Spampinato","year":"2024","unstructured":"Spampinato M, Zuppelli T, Dulcamare I, Longhitano L, Sambataro D, Santisi A, Alanazi AM, Barbagallo IA, Vicario N, Parenti R, Romano A, Musumeci G, Li Volti G, Palumbo GA, Di Raimondo F, Nicolosi A, Giallongo S. Del Fabro V. Enhanced antitumor activity by the combination of dasatinib and Selinexor in chronic myeloid leukemia. Pharmaceuticals (Basel). 2024;17(7):894. https:\/\/doi.org\/10.3390\/ph17070894.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1034_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-022-03635-w","volume":"20","author":"C Zhao","year":"2022","unstructured":"Zhao C, Yang Z, Zhang J, Li O, Liu S, Cai C, Dong P. Inhibition of XPO1 with KPT-330 induces autophagy-dependent apoptosis in gallbladder cancer by activating the p53\/mTOR pathway. J Transl Med. 2022;20:1. https:\/\/doi.org\/10.1186\/s12967-022-03635-w.","journal-title":"J Transl Med"},{"key":"1034_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13619-025-00243-z","volume":"14","author":"L Li","year":"2025","unstructured":"Li L, Xiao Y, Liu L, Zhang Q, Zhang Y, Zhu D, Chen YG. eIF5A maintains intestinal epithelial homeostasis by sustaining intestinal stem cells. Cell Regen. 2025;14:1. https:\/\/doi.org\/10.1186\/s13619-025-00243-z.","journal-title":"Cell Regen"},{"issue":"14","key":"1034_CR52","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1158\/1078-0432.ccr-14-1953","volume":"21","author":"T Miyake","year":"2015","unstructured":"Miyake T, Sunila Pradeep, Wu SY, Rajesha Rupaimoole, Zand B, Wen Y, Wiktorowicz JE. XPO1\/CRM1 Inhibition causes antitumor effects by mitochondrial accumulation of eIF5A. Clin Cancer Res. 2015;21(14):3286\u201397. https:\/\/doi.org\/10.1158\/1078-0432.ccr-14-1953.","journal-title":"Clin Cancer Res"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01034-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01034-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01034-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:42:33Z","timestamp":1763984553000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-01034-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1034"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01034-7","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this study does not involve a clinical trial or human participation, requirements for ethics approval and informed consent are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}